BRPI0910185A2 - sorotipo de reovírus aviário isolado, reovírus aviário isolado, peptídeos, vacina, antisoro isolado, anticorpo isolado, método para proteção de aves, método para detecção ou quantificação de reovírus em aves, recipiente para vacinação de aves, kit para vacinação de aves, kit de diagnóstico, linhagem celular derivada da lmh - Google Patents

sorotipo de reovírus aviário isolado, reovírus aviário isolado, peptídeos, vacina, antisoro isolado, anticorpo isolado, método para proteção de aves, método para detecção ou quantificação de reovírus em aves, recipiente para vacinação de aves, kit para vacinação de aves, kit de diagnóstico, linhagem celular derivada da lmh

Info

Publication number
BRPI0910185A2
BRPI0910185A2 BRPI0910185A BRPI0910185A BRPI0910185A2 BR PI0910185 A2 BRPI0910185 A2 BR PI0910185A2 BR PI0910185 A BRPI0910185 A BR PI0910185A BR PI0910185 A BRPI0910185 A BR PI0910185A BR PI0910185 A2 BRPI0910185 A2 BR PI0910185A2
Authority
BR
Brazil
Prior art keywords
isolated
reovirus
bird
poultry vaccination
avian reovirus
Prior art date
Application number
BRPI0910185A
Other languages
English (en)
Inventor
John Knox Rosenberger
Kristi Mae Dorsey
Sandra Cloud Rosenberger
Original Assignee
Ceva Sante Animale S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Sante Animale S A filed Critical Ceva Sante Animale S A
Publication of BRPI0910185A2 publication Critical patent/BRPI0910185A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/15Reoviridae, e.g. calf diarrhea virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/12011Reoviridae
    • C12N2720/12211Orthoreovirus, e.g. mammalian orthoreovirus
    • C12N2720/12221Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/12011Reoviridae
    • C12N2720/12211Orthoreovirus, e.g. mammalian orthoreovirus
    • C12N2720/12222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/12011Reoviridae
    • C12N2720/12211Orthoreovirus, e.g. mammalian orthoreovirus
    • C12N2720/12234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/12011Astroviridae
    • C12N2770/12034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/14Reoviridae, e.g. rotavirus, bluetongue virus, Colorado tick fever virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
BRPI0910185A 2008-06-26 2009-06-26 sorotipo de reovírus aviário isolado, reovírus aviário isolado, peptídeos, vacina, antisoro isolado, anticorpo isolado, método para proteção de aves, método para detecção ou quantificação de reovírus em aves, recipiente para vacinação de aves, kit para vacinação de aves, kit de diagnóstico, linhagem celular derivada da lmh BRPI0910185A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7610208P 2008-06-26 2008-06-26
PCT/US2009/048860 WO2009158618A2 (en) 2008-06-26 2009-06-26 Unique avian reoviridae

Publications (1)

Publication Number Publication Date
BRPI0910185A2 true BRPI0910185A2 (pt) 2015-12-01

Family

ID=41401860

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0910185A BRPI0910185A2 (pt) 2008-06-26 2009-06-26 sorotipo de reovírus aviário isolado, reovírus aviário isolado, peptídeos, vacina, antisoro isolado, anticorpo isolado, método para proteção de aves, método para detecção ou quantificação de reovírus em aves, recipiente para vacinação de aves, kit para vacinação de aves, kit de diagnóstico, linhagem celular derivada da lmh

Country Status (5)

Country Link
US (1) US9273287B2 (pt)
EP (1) EP2304024A2 (pt)
BR (1) BRPI0910185A2 (pt)
MX (1) MX2010014555A (pt)
WO (1) WO2009158618A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010059899A2 (en) 2008-11-20 2010-05-27 University Of Georgia Research Foundation, Inc. Vaccine for runting-stunting syndrome
RU2018121296A (ru) * 2015-11-12 2019-12-13 Интервет Интернэшнл Б.В. Инактивированная вакцина против реовируса птиц для применения в способе повышения вылупляемости яиц сельскохозяйственных птиц
US10829786B2 (en) * 2018-12-14 2020-11-10 ARV Pharma Inc. Avian oncolytic virus having modified sequences and uses thereof
US20220193220A1 (en) * 2019-05-03 2022-06-23 Kansas State University Research Foundation Immunogenic compositions for novel reassortant mammalian ortheovirus from pigs
CN113832113B (zh) * 2021-09-14 2023-09-22 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) 新型鸭呼肠孤病毒弱毒株及其应用
CN115746130B (zh) * 2022-10-14 2023-10-20 华中农业大学 鸭呼肠孤病毒单克隆抗体NDRV-σC及其检测试剂盒和应用
CN116855458A (zh) * 2023-07-21 2023-10-10 华中农业大学 新型鸭呼肠孤病毒QR-China/2020及其应用
CN119876484A (zh) * 2024-11-06 2025-04-25 佛山大学 基因ⅰ型和ⅱ型鹅源呼肠孤病毒双重荧光定量pcr引物及试剂盒

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL74289A (en) * 1985-02-10 1989-02-28 Israel State Vaccine system comprising a live-non-virulent vaccine and an adjuvant
US5443982A (en) 1993-07-13 1995-08-22 Solvay Animal Health, Inc. Methods for the cultivation of infectious laryngotracheitis virus
JP4659942B2 (ja) 1999-01-29 2011-03-30 インターベツト・インターナシヨナル・ベー・ベー トリレオウイルスの新規抗原クラス
CA2498768A1 (en) 2002-10-09 2004-04-22 Akzo Nobel N.V. Methods of treating and preventing neurological symptoms caused by avian reovirus and novel associated characteristics
US8178110B2 (en) * 2006-10-25 2012-05-15 University Of Georgia Research Foundation, Inc. Reovirus compositions and methods of use
SG191602A1 (en) * 2007-03-12 2013-07-31 Oncolytics Biotech Inc Reoviruses having modified sequences

Also Published As

Publication number Publication date
WO2009158618A3 (en) 2010-04-22
MX2010014555A (es) 2011-04-27
US9273287B2 (en) 2016-03-01
WO2009158618A4 (en) 2010-06-24
WO2009158618A2 (en) 2009-12-30
EP2304024A2 (en) 2011-04-06
WO2009158618A8 (en) 2011-02-10
US20110150928A1 (en) 2011-06-23

Similar Documents

Publication Publication Date Title
BRPI0910185A2 (pt) sorotipo de reovírus aviário isolado, reovírus aviário isolado, peptídeos, vacina, antisoro isolado, anticorpo isolado, método para proteção de aves, método para detecção ou quantificação de reovírus em aves, recipiente para vacinação de aves, kit para vacinação de aves, kit de diagnóstico, linhagem celular derivada da lmh
BRPI0910195A2 (pt) sorotipo de astrovírus isolado, sequência de nucleotídeos isolada, construção contendo uma sequência de nucleotídeos isolada, vetor, sequência de polipeptídeos, vacina, antisoro isolado, anticorpo isolado, método para proteção ou vacinação de aves, método de ensaio diagnóstico, recipiente para a vacinação de aves, kit para a vacinação de aves, kit diagnóstico, método para propagar o astrovirus, linhagem celular para a propagação do isolado de astrovírus
BRPI0822726A2 (pt) Aparelho para aquisição de dados, sistema de aquisição de dados e métodos de aquisição de dados
BRPI0914801A2 (pt) método para detectar o grupo sanguíneo abo/rh/mn humano, e, kit
BRPI0823224A2 (pt) Método e sistema para determinação de dados de estrada
BRPI0913145A2 (pt) método para identificar automaticamente malware e sistema para identificar automaticamente malware
BRPI1006077A2 (pt) sistema e metodo para analisar as propriedades de carnes usando imageamento multiespectral
MX387936B (es) Metodo para la cuantificacion de huevos de parasitos en las heces.
BRPI1006885A2 (pt) sistema de completação utilizável com um poço, e método utilizável com um poço
BR112013030616A2 (pt) aparelho de teste para coletar uma ou mais amostras de fluido de fundo de poço a partir de um furo de poço, e método para capturar uma amostra a partir de um furo de poço.
BRPI0914925A2 (pt) peptídeo cíclico, uso de um peptídeo, métodos para produzir um peptídeo cíclico e para diagnosticar uma doença ou condição, e, anticorpo
BRPI0807695A2 (pt) Aparelho e método para aquisição e/ou detecção automàtica de dados
BRPI0917757A2 (pt) sistema de imagem, meio de armazenamento digital que armazena instruções executáveis para realizar um método e método
IL213189A (en) Vaccine comprising avian influenza antigen, method of vaccinating an animal therewith, dna encoding the antigen and uses thereof
BRPI0916447A2 (pt) sistema para realizar um levantamento subterrâneo marinho, método de realizar um levantamento subterrâneo marinho, e aparelho para realizar um levantamento subterrâneo marinho
BRPI1014232A2 (pt) aparelho para gerar múltiplas árvores de codificação de candidato para uso durante codificação, sistema para codificação e de codificação adaptável de imagens ou vídeos, e, método para gerar múltiplas árvores de codificação de candidato
BRPI0823030A2 (pt) Sistema de elevador, e, método para fazer um sistema de elevador.
PT2198288T (pt) Método e aparelho para miragem de ovos por meio de deteção de batimento cardíaco do embrião
BRPI1013177A2 (pt) construto de ligação de antígeno, polipeptídeo isolado, e, método para tratar doença cardíaca
BR112013008602A2 (pt) dispositivo imunocromatográfico, método para a determinação de um carreador gênico, método para o diagnóstico, dispositivo para ensaio imunológico, método para a detecção e determinação da presença de uma proteína e kit
BR112014029274A2 (pt) anticorpo isolado, composição farmacêutica, uso do anticorpo, método para tratar infecção rábica, kit para tratar infecção rábica, kit para detectar vírus rábico, ácido nucleico isolado, e, célula hospedeira.
BRPI1014113A2 (pt) método de processamento de dados sísmicos com base em campo de onda , e, sistema configurado para realizar processamento de dados sísmicos com base em campo de onda.
BR112012014678A2 (pt) "uso do dna mrna, método para o diagnóstico da rosácea e método de monitoramento"
BRPI0812321A2 (pt) Sais de ácido etilenodiamina dissuccínico, composição contendo os ditos sais, uso e método de preparação destes.
BRPI0910166A2 (pt) sistema e, método

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa)
B06T Formal requirements before examination
B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal
B09B Decision: refusal

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL